Pernix Therapeutics Names John Sedor As Chairman and Interim CEO In Place Of Dough Drysdale
May 11, 2016 at 13:51 PM EDT
Pernix Therapeutics Holdings, Inc. (NASDAQ: PTX), a specialty pharmaceutical firm, appointed its Director, John Sedor, as its ...